CLINICAL_TRIALS
trial_result
· 2013-10-10
Clinical Trial Update: (A Novel Pharmacologic Regime for Elective Percutaneous Coronary Intervention) [Phase 3]
Summary
Phase 3 trial update for a novel pharmacologic regime used in elective percutaneous coronary intervention. The trial has completed and results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Bursa Postgraduate Hospital | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED | Results posted: 2013-10-10